TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
-$157M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$44.9M
2
+$33.2M
3
+$32.7M
4
CDTX icon
Cidara Therapeutics
CDTX
+$26.1M
5
RAPT icon
RAPT Therapeutics
RAPT
+$19.8M

Top Sells

1
+$56.4M
2
+$7.62M
3
+$5.21M
4
ANTX icon
AN2 Therapeutics
ANTX
+$1.66M
5
ADVM icon
Adverum Biotechnologies
ADVM
+$989K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$105M 10.29%
3,670,206
2
$62.4M 6.1%
2,650,150
3
$56.4M 5.51%
2,452,138
+25,000
4
$54.3M 5.31%
6,964,375
5
$48.4M 4.73%
2,890,816
6
$45.4M 4.44%
5,319,148
7
$44.9M 4.38%
+2,801,763
8
$44.3M 4.33%
6,056,596
9
$38M 3.71%
12,362,205
10
$33.2M 3.24%
+10,736,000
11
$32.7M 3.2%
+1,501,624
12
$30.9M 3.02%
486,957
13
$30.4M 2.97%
2,470,265
14
$30M 2.93%
1,477,593
15
$28.8M 2.82%
1,063,000
16
$27.6M 2.7%
1,989,103
17
$26.6M 2.6%
3,572,335
+2,650,000
18
$26.1M 2.55%
+1,005,901
19
$25.8M 2.52%
2,505,424
+90,424
20
$24.7M 2.42%
550,000
21
$24.7M 2.41%
2,761,861
22
$24.7M 2.41%
5,250,000
23
$20.9M 2.04%
3,033,560
24
$19.8M 1.93%
+1,641,908
25
$17.6M 1.72%
4,643,812
1
2